Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M306Revenue (TTM) $M1.0Net Margin (%)-2,992.7Altman Z-Score21.1
Enterprise Value $M209EPS (TTM) $-0.2Operating Margin %-3,125.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.1Pre-tax Margin (%)-2,992.7Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %--Quick Ratio16.5Cash flow > EarningsY
Price/Sales3205-y EBITDA Growth Rate %--Current Ratio16.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-22.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-24.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M159ROIC % (ttm)-200.6Gross Margin Increase y-yN

Gurus Latest Trades with GERN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GERN is held by these investors:



GERN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEHRS MELISSA KELLYEVP BD and Port&Alliance Mgmt 2015-05-29Sell2,380$3.84-49.74view
Bloom Olivia KyusukEVP, CFO 2015-05-29Sell2,380$3.84-49.74view
Hofstaetter ThomasDirector 2015-03-18Sell70,000$4.1-52.93view
Bloom Olivia KyusukEVP, CFO 2014-05-29Sell3,379$2.1-8.1view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-05-29Sell4,826$2.1-8.1view
BRADBURY DANIELDirector 2014-05-09Buy142,776$1.7510.29view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-04-01Sell12,310$2.13-9.39view
Bloom Olivia KyusukEVP, CFO 2014-04-01Sell7,435$2.13-9.39view
SCARLETT JOHN APresident and CEO 2013-04-01Buy50,000$1.0387.38view
BEHRS MELISSA KELLYSVP Alliance and Prog Mgmt 2013-01-17Sell28,292$1.6516.97view

Press Releases about GERN :

Quarterly/Annual Reports about GERN:

News about GERN:

Articles On GuruFocus.com
Geron Announces November Investor Conference Presentation Webcasts Nov 07 2017 
Geron Corporation Reports Third Quarter 2017 Financial Results Nov 01 2017 
Geron Announces Presentations at American Society of Hematology Annual Meeting Nov 01 2017 
Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndrome Oct 31 2017 
Geron Announces Conference Call to Discuss Third Quarter 2017 Financial Results Oct 25 2017 
Geron to Present at the Cantor Fitzgerald Healthcare Conference Sep 19 2017 
Geron Corporation Reports Second Quarter 2017 Financial Results Aug 09 2017 
Geron Announces Updates to Imetelstat Clinical Development Jul 31 2017 
Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events May 09 2017 
Faruqi & Faruqi, LLP Announces a Proposed Class Action Settlement Involving All Persons who Purchase May 01 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK